Jan Sigger

BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands.

The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom.

National Health Service provides health care services. It offers hospital services, family doctors, dentists, opticians and pharmacists and local authority health services, community nursing and health care services. The company was founded by Aneurin Bevan on July 5, 1948 and is headquartered in London, the United Kingdom.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Holland Capital Management BV (Holland Capital) is an independent private equity & venture capital firm founded in 1981. The firm is headquartered in Amsterdam, the Netherlands.

Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden.

Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France.

eZono AG develops portable ultrasound system. Its product eZono 3000 is a portable ultrasound system designed for the needs of anaesthetists. The company was founded by Allan R. Dunbar and Andre Jaekel in July 2004 and is headquartered in Jena, Germany.

Ontwikkelingsmaatschappij Oost Nederland NV (Development Agency East Netherlands) is an Independent Private Equity/Venture Capital firm that focuses its activities on strengthening the economy of the provinces of Gelderland and Overijssel, the Netherlands. Oost NV is headquartered in Apeldoorn.

InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.

Team Consulting Ltd. provides product development consulting services. It assists its clients at every stage of the product development process, which cover: product strategy, due diligence, user research, industrial design, risk analysis, product engineering, and industrialization. The company was founded by Andy Fry, Perran Newman, Alan Goodman, John Targell and Peter Sharpe on November 11, 1986 and is headquartered in Cambridge, the United Kingdom.

Part of Terumo Corp., Terumo (Deutschland) GmbH is a German company that manufactures and sells medical equipment. The company is based in Eschborn, Germany. The company was founded in 2013. The CEO is Norimasa Kunimoto.

Bioxydyn Ltd. provides magnetic resonance imaging applications and services. Its services include imaging protocol and charter, on-site and remote training, quality management, and quantitative imaging biomarkers. The company was founded by Geoffrey James Martin Parker in 2009 and is headquartered in Manchester, the United Kingdom.

National Institute for Health & Care Excellence provides national guidance and advice to improve health and social care. The firm's programs include financial planning, advice, shared learning, standards and indicators and topic selections. The company was founded in 1999 and is headquartered in London, the United Kingdom.

Philips Healthcare engages in the manufacture of electromedical apparatus. It develops products that offer added value to the entire care cycle: from disease prevention to screening, diagnosis, treatment and follow-up care at home or in hospital. It also deals with cardiology, oncology, and women's health. It focuses on serious health problems, which people are confronted, such as heart problems, lung and breast disease. The company is headquartered in Eindhoven, the Netherlands.

Picker Institute Europe provides health and social care services. The non-profit company is based in Oxford, UK. The British company was founded in 2000. Chris Graham has been the CEO of the company since 2011.

ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA.

Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands.

Ventinova Medical BV develops and markets products in the field of anesthesiology. Its products include Ventrain, Cricath, and Ventrain Emergency Kit. The company was founded by Dirk van Asseldonk in 2013 and is headquartered in Eindhoven, Netherlands.

SurgVision BV provides optical imaging camera systems. It develops integrated optical imaging platforms, including camera, software and target specific tracer, for specific disease areas like breast cancer surgery. The company was founded by Vasilis Ntziachristos and Ton van den Hoven in 2011 and is headquartered in 't Harde, the Netherlands.

Part of Version 1 Software Ltd., Version 1 Solutions Ltd. is a digital service provider that enables private and public sector customers to efficiently deliver digital solutions and engage with users. The company is based in London, UK and was founded in 1997. The British company provides a range of services including cloud migration, managed services, data and analytics, and ERP solutions. The company also offers branding guidelines and logos for presentations and marketing materials. Version 1 Solutions is committed to maintaining an innovation edge to drive customer success and being a responsible business while complying with all relevant legal acts. The CEO is Tom O'Connor. Version 1 Solutions was acquired by Version 1 Software Ltd. on January 12, 2015.

Rutherford Health Plc is a holding company, which engages in the provision of cancer treatment research and technology services. It operates oncology centers that offers a range of cancer treatments to patients including radiotherapy, chemotherapy, imaging, and ancillary well-being services. The company was founded by Michael Moran and Karol Sikora on February 4, 2015 and is headquartered in Hereford, the United Kingdom.

Part of Terumo Corp., Terumo UK Ltd. markets and sells a wide range of quality products for angiography, cardiology and cardiovascular surgery, embolotherapy, infusion systems and injection. The company is based in Bagshot, UK.

Livassured BV develops monitoring devices for epilepsy patients that identifies nocturnal seizures. The company was founded by Mark Bloemendaal and Asmund Tielens and is headquartered in Vught, the Netherlands.

Cashflex Factoring BV offers financing and credit management solutions services to optimize working capital of the company for business expense with low interest rates. The company was founded in 2014 is headquartered in Arnhem, the Netherlands.

NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands.

Redmedtech Discovery Fund is an independent private equity firm with its headquarters in Apeldoorn, the Netherlands. It was founded in 2014.

BV HealthConnected is a healthcare platform that aims to improve the quality of care by using ICT. The company is based in Alkmaar, Netherlands, and has a clear vision of how ICT can improve healthcare. The platform connects thousands of care providers and millions of patients, and it is designed for primary care, network care, and the entire region. The Dutch company values information security and has a flexible CISO. The company also has an e-learning application and share their success stories and knowledge on various topics through their publications. BV HealthConnected offers vacancies for those who want to contribute to society. Paul Witteman has been the CEO of the company since 2018.

Part of Netherlands Foreign Investment Agency, the Dutch company provides investment advisory services.

KHP Medtech Innovations Ltd (KHP Medtech Innovations) is a private equity & venture capital firm founded in 2021. The firm is headquartered in London, United Kingdom.

Xilloc Medical Int BV is a Dutch company that manufactures medical instruments, implants, and anatomical models. The company is based in Sittard-Geleen, the Netherlands, and has subsidiaries in the Netherlands. The company was founded in 2003 by Maikel Beerens, and the CEO is Milko Wijckmans.

NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands.